Evidence map›Paper›PMID 38102297›Full record

SynthesisScientific reports2023

Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease.

Hristo Kirov, Tulio Caldonazo, Leoni Lu Riedel, Panagiotis Tasoudis, Alexandros Moschovas, Mahmoud Diab, Gloria Färber, Torsten Doenst

Open access · goldAbstract readComparative StudyMeta-Analysis
In one paragraph

Synthesis in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hristo Kirov *Department of Cardiothoracic Surgery, Friedrich-Schiller-University, Jena, Germany.
Tulio Caldonazo *Department of Cardiothoracic Surgery, Friedrich-Schiller-University, Jena, Germany.
Leoni Lu RiedelDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University, Jena, Germany.
Panagiotis TasoudisDivision of Cardiothoracic Surgery, University of North Carolina, Chapel Hill, USA.
Alexandros MoschovasDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University, Jena, Germany.
Mahmoud DiabDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University, Jena, Germany.
Gloria FärberDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University, Jena, Germany.
Torsten DoenstDepartment of Cardiothoracic Surgery, Friedrich-Schiller-University, Jena, Germany. doenst@med.uni-jena.de.
Friedrich Schiller University Jena · DEUniversity of North Carolina at Chapel Hill · US

Funding

Deutsche Forschungsgemeinschaft 413668513Deutsche Herzstiftung S/03/23Thoracic Surgery Foundation MPS
6 · The paper itself

Abstract

Mechanisms of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) differ as CABG provides surgical collateralization and may prolong life by preventing future myocardial infarctions (MI). However, CABG benefits are unclear in octogenarians, where surgical risk is often perceived as higher and PCI is chosen more liberally. We performed a meta-analysis of studies comparing outcomes in octogenarians with left main or multivessel disease who underwent CABG or PCI. Primary outcome was late mortality (> 5 years). Secondary outcomes were perioperative mortality, MI, re-revascularization (R-R), acute renal failure (ARF), and stroke. Fourteen studies with 17,942 patients were included. CABG was associated with lower late mortality (hazard ratio, HR: 1.23, 95% confidence interval: CI 1.05-1.44, p < 0.01). In the pooled Kaplan-Meier analysis CABG showed significantly lower risk of death in the follow-up compared to PCI (HR: 1.08, 95%CI 1.02-1.41, p = 0.005). Landmark analyses confirmed the survival advantage of CABG over PCI after 21.5 months of follow-up (HR: 1.31, 1.19-1.44, p < 0.0001), but suggested advantage of PCI over CABG in the first 30-days (HR: 0.72, 0.64-0.82, p < 0.0001) and comparable survival from 1 to 21.5 months (HR: 0.98, 0.92-1.05, p = 0.652). We found lower risk for MI and R-R after CABG but higher perioperative mortality and no differences in ARF and stroke. CABG appears superior to PCI over time in octogenarians with complex CAD. This survival advantage is associated with fewer events of MI and R-R; however, it comes with an increased risk in perioperative mortality.

Indexed as

Coronary Artery BypassCoronary Artery DiseasePercutaneous Coronary InterventionAged, 80 and overHumansMyocardial InfarctionOctogenariansStrokeTreatment Outcome

Identifiers

PMID38102297
PMCPMC10724226
OpenAlexW4389820025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.